Table 3: Comparison plasma total L-carnitine, L-lysine concentrations and HIV-1 RNA levels in HIV-infected patients.

HIV-Patients HIV-1 RNA (copies/ml) ±s.e. Total L-Carnitine (µmol/l) Pearson's Correlation Coefficient L-lysine (µmol/l) Pearson's Correlation Coefficient
The entire cohort n=430 205.700±24.450 27.8±7.1 r= - 0.14, P<0.048 (S) 224.1±128.3 r= - 0.21,
P<0.017 (S)
Group I
(A1, A2)
n=240 		109.300±10.300 33.1±7.8 r= - 0.09, P>0.05 (NS) 253.1±144.9 r= - 0.19,
P<0.01 (S)
Group II
(B1, B2)
n=130 		186.700±21.400 29.4±7.7 r= - 0.15, P<0.043 (S) 212.3±135.0 r= - 0.24,
P<0.02 (S)
Group III
(C1, C2)
n=60 		321.100±44.670 26.1±5.8 r= - 0.28, P<0.019(S) 149.1±110.5 r= - 0.43,
P<0.01 (S)
HIV-infected patients under HAART
n=125 		0.500±0.45 25.7±4.4 r= - 0.05, P>0.05 (NS) 283.0±142.7 r= - 0.10, P>0.05 (NS)

(S): Differences were considered significant when P < 0.05
(NS): not significant
Values are given as mean±s.d., except for the viral load (mean±s.e.)